10x Genomics Launches Xenium Catalyst Network
Founding Network Members Will Accelerate Access to Proof-of-Concept Data for Prospective Xenium Customers Worldwide
PLEASANTON, Calif., Dec. 20, 2023 /PRNewswire/ — 10x Genomics, Inc., (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of its Xenium Catalyst Network, a global group of technically qualified research institutions that will accelerate access to Xenium proof-of-concept data for researchers worldwide. The four founding members of the Xenium Catalyst Network will add significant capacity for the company’s Xenium Catalyst Program, a technical access service launched earlier this year for prospective customers.
Related news for (TXG)
- 24/7 Market News Snapshot 20 October, 2025 – 10x Genomics, Inc. Class A Common Stock (NASDAQ:TXG)
- 10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
- Addentax Group Corp. Announces Strategic Cooperation Discussions with KINGS UNITED to Advance Web3.0 and RWA Initiatives
- 10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
- Breaking News: MoBot’s Latest Update as of 09/22/25 03:00 PM
